Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Fast-track Giant Ventral Hernia Repair

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliImekamilika
Wadhamini
Bispebjerg Hospital

Maneno muhimu

Kikemikali

The implementation of an enhanced recovery pathway after giant ventral hernia repair, including preoperative high-dose steroid is examined prospectively and compared with a group of historic controls.

Maelezo

All patients operated on for a large incisional hernia are treated according to the study protocol. Patients are given high-dose glucocorticoid preoperative and the aim is to discharge patients at postoperative day 3.

Morbidity, length of stay, pain, nausea and pulmonary function are among registered outcomes compared with a historic control group.

Tarehe

Imethibitishwa Mwisho: 08/31/2015
Iliyowasilishwa Kwanza: 11/10/2014
Uandikishaji uliokadiriwa Uliwasilishwa: 11/26/2014
Iliyotumwa Kwanza: 12/01/2014
Sasisho la Mwisho Liliwasilishwa: 09/02/2015
Sasisho la Mwisho Lilichapishwa: 09/06/2015
Tarehe halisi ya kuanza kwa masomo: 11/30/2014
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 06/30/2015
Tarehe ya Kukamilisha Utafiti: 06/30/2015

Hali au ugonjwa

Hernia, Ventral

Uingiliaji / matibabu

Other: Fast-track group

Awamu

-

Vikundi vya Arm

MkonoUingiliaji / matibabu
Fast-track group
Patients treated according to the enhanced recovery pathway. This group is examined prospectively.
Other: Fast-track group
Enhanced recovery after surgery pathway. Postoperatively, a set of well-defined discharge criteria will be assessed daily at 9:00 and 15:00, as well as pain, nausea, time to flatus, saturation and drain production.
Control group
Patients treated according to the historic recovery pathway. This group is examined retrospectively.

Vigezo vya Kustahiki

Jinsia Inastahiki KujifunzaAll
Njia ya sampuliNon-Probability Sample
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

- Horizontal fascia defect > 10 cm on computed tomography scan

- Planned elective open incisional hernia repair

Exclusion Criteria:

- Known allergy against glucocorticoid treatment

- Insulin-treated diabetes

- Gastric ulcer diagnosed within four weeks preoperative

- Steroid-treated immune disease

- Planned intestinal anastomosis concomitant to hernia repair

Matokeo

Hatua za Matokeo ya Msingi

1. Time to discharge [Participants will be followed for the duration of hospital stay, an expected average of 72 hours]

Time from surgery to discharge [Hours].

Hatua za Matokeo ya Sekondari

1. Fatigue [Preoperative and for the duration of hospital stay, an expected average of 3 days]

Preoperative and twice daily (9 and 15) postoperative. Measured by a numerical rating scale (1 = No fatigue, 5 = Exhausted).

2. Pain from supine to standing [Preoperative and for the duration of hospital stay, an expected average of 3 days]

Preoperative and twice daily (9 and 15) postoperative. Measured by a numerical rating scale (1 = No pain, 5 = Intolerable pain)

3. Pain when walking 6 meters [Preoperative and for the duration of hospital stay, an expected average of 3 days]

Preoperative and twice daily (9 and 15) postoperative. Measured by a numerical rating scale (1 = No pain, 5 = Intolerable pain)

4. Nausea [Preoperative and for the duration of hospital stay, an expected average of 3 days]

Preoperative and twice daily (9 and 15) postoperative. Measured by a numerical rating scale (1 = No nausea, 5 = Intolerable nausea)

5. Time to bowel function [For the duration of postoperative hospital stay, an expected average of 72 hours]

The time to bowel function [hours] will be registered for each participant

6. Vomiting episodes [Participants will be followed for the duration of hospital stay, an expected average of 3 days]

The daily number of vomiting episodes will be registered for each participant

7. Continuous transcutaneous saturation [From surgery to postoperative day 3 at 12 pm]

Continuous transcutaneous oxygen saturation (percentage), measured by Pulsox 300i (C) (Konica Minolta, Osaka, Japan)

8. C-reactive protein from venous blood sample [Preoperative and for the duration of hospital stay, an expected average of 3 days]

Daily C-reactive protein measured in a venous blood sample.

9. Ear temperature [Preoperative and for the duration of hospital stay, an expected average of 3 days]

Ear temperature (celsius degree) measured daily at 9 and 15.

10. Detailed reason for not being discharged if criteria are otherwise fulfilled [From surgery and for the duration of hospital stay, an expected average of 3 days]

The reason(s) for participants not being discharged if discharge criteria are otherwise fulfilled.

11. Daily wound drain production [From surgery and for the duration of hospital stay, an expected average of 3 days]

Daily registration of the fluid volume [milliliters] in the wound drains postoperative.

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge